Our News | HKBU R&D Licensing Limited, Hong Kong Baptist University

Home

Media Hub

Our News

OUR MISSION

To enable enterprises to drive business growth through our Innovative solutions and one-stop services.

OUR VISION

To inspire talents, nurture leaders, excite entrepreneurship stakeholders and expand our global business network to create a better future.

OUR VALUE

To add value to our partners through transferring research innovation and expert knowledge, so that we can co-create Win-Win-Win situations for the society, businesses, and HKBU.

Get More Ideas

All Topics Solutions Research Advancement Research Advancement (Industry)Research Advancement (Staff)Enterprise Enterprise (Industry)Enterprise (Staff)Innovation Technology Transfer Knowledge Transfer Art and Culture Technology Healthcare Research and Impact Awards Events Funding Startup

Enterprise (Industry), Enterprise (Staff), Startup

HKBU Spin-off Company Highlight: Making the Leap from Laboratory to Market - Dr Lung Hong-lok

Mar 1, 2021

Dr Lung Hong-lok is an Assistant Professor from the Department of Chemistry at HKBU as well as the Co-founder and Chief Scientific Officer of BP InnoMed Limited (BPI). He is recognised for developing a new EBV-specific targeted therapy and commercialising the innovative cancer research discoveries. BPI has developed a novel drug which has the potential to become a next-generation treatment for cancers associated with Epstein–Barr virus (EBV).